Title Clinicopathological Spectrum of Cryoglobulinemic Glomerulonephritis without Evidence of Autoimmunity Disorders: A Retrospective Study from a Single Institute of China
Authors Zhang, Xin
Yu, Xiao-Juan
An, Chong-Wen
Yong, Zi-Hao
Wang, Su-Xia
Zhou, Fu-de
Zhao, Ming-Hui
Affiliation Peking Univ, Renal Div,Minist Educ China, Dept Med,Key Lab Renal Dis,Minist Hlth China,Key, Peking Univ First Hosp,Inst Nephrol,Renal Pathol, Beijing, Peoples R China
Peking Univ First Hosp, Clin Lab, Beijing, Peoples R China
Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China
Peking Univ First Hosp, Pathol Ctr, Lab Electron Microscopy, Beijing, Peoples R China
Keywords MIXED CRYOGLOBULINEMIA
VASCULITIS
MULTICENTER
RITUXIMAB
SURVIVAL
FEATURES
Issue Date May-2022
Publisher KIDNEY DISEASES
Abstract Background: Cryoglobulinemic glomerulonephritis (Cryo-GN), caused by circulating cryoglobulins, has varied etiology and clinical-pathologic manifestations. This study aimed to investigate the clinicopathological spectrum and outcome of patients with various Cryo-GN in China. Methods: A retrospective review of 74 Chinese patients with biopsy-proven cryoglobulin-related renal lesions in Peking University First Hospital from 2010 to 2020 was performed. Results: The mean age at diagnosis was 52.9 +/- 15.0 years, and the female-to-male ratio was about 2/5. For the etiology screening, serum/urine monoclonal immunoglobulin could be detected on immunofixation electrophoresis in 34% of patients, including 6 patients who had hematological malignancies. Fifty-seven percent of patients had HBV infection, far more than HCV infection (5%). Ten percent of patients had other infections, and 27% of patients were classified as essential or idiopathic. Eleven out of the 15 patients with type II cryoglobulinemia had a consistent monotype of serum monoclonal immunoglobulins and monoclonal cryoprecipitate. The clinical manifestations were similar between various types of cryoglobulinemia. Hematuria, proteinuria, hypertension, anemia, and chronic renal insufficiency were the most common features. Fifty-three percent of patients presented with nephrotic syndrome, and 32% experienced acute kidney injury. Hypocomplementemia, serum-positive rheumatoid factor activity, and skin lesions were reported in 45%, 29%, and 28% of patients, respectively. After a median of 24 months follow-up, 18 patients reached end-stage kidney disease. The clone-targeted treatment could retard the renal deterioration compared with immunosuppressive therapy. Conclusions: This was the largest single-center, clinicopathological retrospective study of Cryo-GN in China. Our data strongly support the association between monoclonal gammopathy and type II Cryo-GN. The renal responsive rate of immunosuppressant therapy is still suboptimal. The clone-targeted treatment shows promising effects in patients with type I or II Cryo-GN. (C) 2022 The Author(s). Published by S. Karger AG, Basel
URI http://hdl.handle.net/20.500.11897/648789
ISSN 2296-9381
DOI 10.1159/000522537
Indexed SCI(E)
Appears in Collections: 第一医院

Files in This Work
There are no files associated with this item.

Web of Science®


0

Checked on Last Week

Scopus®



Checked on Current Time

百度学术™


0

Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.